Popular weight-loss drug Wegovy goes on sale in ChinaWeight loss treatment becomes available to more than 180 million people living with obesity in ChinaAccording to Chinese business news website Yicai, a dose of four Wegovy injections will cost 1,400 yuan (£153; $194), a fraction of the drug's price in the United States.
More than 180 million people live with obesity in China, which has a population of 1.4 billion.
It is set to intensify competition with rival Eli Lilly, whose popular weight-loss treatment also got the green light months ago but has yet to go on sale in the world's second largest pharmaceutical market.
Novo Nordisk has launched its weight-loss drug Wegovy in China after it was approved by local health authorities in June.
Research suggests that Wegovy patients can lose more than 10% of their body weight.